Skip to content
10-Q

Quarterly Report

Surmodics, Inc.

0000950170-25-060582

← back to feed
Filed
Apr 30, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Apr 25, 2025 14.3M sh
Shares Diluted Q2 2025 · Mar 31, 2025 14.28M sh
Shares Diluted Q2 2025 · Mar 31, 2025 14.26M sh
Shares Diluted Q2 2025 · Mar 31, 2024 14.18M sh
Shares Diluted Q2 2025 · Mar 31, 2024 14.13M sh
Capex Q2 2025 · Mar 31, 2025 $621K
Capex Q2 2025 · Mar 31, 2024 $1.99M
Operating Cash Flow Q2 2025 · Mar 31, 2025 −$6.95M
Operating Cash Flow Q2 2025 · Mar 31, 2024 −$1.38M
Cash And Equivalents Q2 2025 · Mar 31, 2025 $29.18M
Cash And Equivalents Q2 2025 · Sep 30, 2024 $36.12M
Stockholders Equity Q2 2025 · Mar 31, 2025 $110.25M
Stockholders Equity Q2 2025 · Dec 31, 2024 $111.77M
Stockholders Equity Q2 2025 · Sep 30, 2024 $118.9M
Stockholders Equity Q2 2025 · Mar 31, 2024 $123.95M
Stockholders Equity Q2 2025 · Dec 31, 2023 $122.15M
Stockholders Equity Q2 2025 · Sep 30, 2023 $119.91M
Current Liabilities Q2 2025 · Mar 31, 2025 $13.95M
Current Liabilities Q2 2025 · Sep 30, 2024 $20.54M
Total Liabilities Q2 2025 · Mar 31, 2025 $52.97M
Total Liabilities Q2 2025 · Sep 30, 2024 $59.67M
Current Assets Q2 2025 · Mar 31, 2025 $71.75M
Current Assets Q2 2025 · Sep 30, 2024 $81.3M
Total Assets Q2 2025 · Mar 31, 2025 $163.21M
Total Assets Q2 2025 · Sep 30, 2024 $178.56M
Eps Diluted Q2 2025 · Mar 31, 2025 −$0.36
Eps Diluted Q2 2025 · Mar 31, 2025 −$0.62
Eps Diluted Q2 2025 · Mar 31, 2024 $0.02
Eps Diluted Q2 2025 · Mar 31, 2024 −$0.04
Eps Basic Q2 2025 · Mar 31, 2025 −$0.36
Eps Basic Q2 2025 · Mar 31, 2025 −$0.62
Eps Basic Q2 2025 · Mar 31, 2024 $0.02
Eps Basic Q2 2025 · Mar 31, 2024 −$0.04
Sga Expense Q2 2025 · Mar 31, 2025 $15.05M
Sga Expense Q2 2025 · Mar 31, 2025 $30.22M
Sga Expense Q2 2025 · Mar 31, 2024 $13.09M
Sga Expense Q2 2025 · Mar 31, 2024 $25.63M
Net Income Q2 2025 · Mar 31, 2025 −$5.21M
Net Income Q2 2025 · Mar 31, 2025 −$8.86M
Net Income Q2 2025 · Mar 31, 2024 $247K
Net Income Q2 2025 · Mar 31, 2024 −$539K
Operating Income Q2 2025 · Mar 31, 2025 −$4.01M
Operating Income Q2 2025 · Mar 31, 2025 −$6.49M
Operating Income Q2 2025 · Mar 31, 2024 $659K
Operating Income Q2 2025 · Mar 31, 2024 $337K
Cost Of Revenue Q2 2025 · Mar 31, 2025 $7.83M
Cost Of Revenue Q2 2025 · Mar 31, 2025 $15.26M
Cost Of Revenue Q2 2025 · Mar 31, 2024 $7.1M
Cost Of Revenue Q2 2025 · Mar 31, 2024 $15.9M
Revenue Q2 2025 · Mar 31, 2025 $28.09M
Revenue Q2 2025 · Mar 31, 2025 $58.01M
Revenue Q2 2025 · Mar 31, 2024 $31.96M
Revenue Q2 2025 · Mar 31, 2024 $62.51M